© 2021 MJH Life Sciences™ and Oncology Nursing News. All rights reserved.
Dr. Tripathy on the Development of Palbociclib in Breast Cancer
August 24, 2015
Debu Tripathy, MD
Debu Tripathy, MD
Debu Tripathy, MD, chair of the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, discusses the development of palbociclib (Ibrance) in breast cancer.
Debu Tripathy, MD, chair of the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, discusses the development of palbociclib (Ibrance) in breast cancer.
Related Content: